We suggested that it is the linkage between VEGF, blood vessel maintenance and tumor metabolism that explains the profound initial effects of BEV on GBM and postulated that its magnitude will be proportional to the real time relative OXPHOS and GLY processes observed within tumor tissue after anti-angiogenic therapy [19]. This evidence concerns the gene VEGFA and glioblastoma.